4
MARKET OVERVIEW
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Presents a concise view of industry direction, strategic priorities, and key indicators influencing market momentum.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
THREAT OF SUBSTITUTES
5.1.3
BARGAINING POWER OF SUPPLIERS
5.1.4
BARGAINING POWER OF BUYERS
5.1.5
INTENSITY OF COMPETITION RIVALRY
5.2
MACROECONOMIC OUTLOOK
5.2.1
GDP TRENDS AND FORECAST
5.2.2
TRENDS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
5.2.3
TRENDS IN HEALTHCARE/PHARMA INDUSTRY
5.4.1
EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFTS
5.5.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024
5.5.2
AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10
IMPACT OF 2025 US TARIFF – NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1.2
MAGNETIC-BEAD BASED TECHNOLOGY
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
ADVANCED SAMPLE LYSIS AND INHIBITOR-REMOVAL CHEMISTRIES
6.3
ADJACENT TECHNOLOGIES
6.3.1
MICROFLUIDIC EXTRACTION
6.3.2
EXTRACTION-FREE AMPLIFICATION
6.4
TECHNOLOGY/SERVICE ROADMAP
6.7
IMPACT OF AI/GEN AI ON NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.3
CERTIFICATIONS, LABELING, & ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY TYPE (MARKET SIZE 2023–2030, FORECAST TO 2030 – IN VALUE, USD MILLION)
COMPARATIVE ASSESSMENT OF KEY KIT TYPES, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
9.4
TOTAL NUCLEIC ACID ISOLATION KITS
10
NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY METHOD, (MARKET SIZE 2023–2030, FORECAST TO 2030 – IN VALUE, USD MILLION)
COMPARATIVE ASSESSMENT OF KEY METHODS, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
11
NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY APPLICATION, (MARKET SIZE 2023–2030, FORECAST TO 2030 – IN VALUE, USD MILLION)
APPLICATION-WISE DEMAND POTENTIAL AND GROWTH PATHWAYS SHAPING NUCLEIC ACID ISOLATION AND PURIFICATION KITS ADOPTION IN DIVERSE INDUSTRIES
11.3
DRUG DISCOVERY AND DEVELOPMENT
11.4
PERSONALIZED MEDICINE
11.5
AGRICULTURE AND ANIMAL RESEARCH
12
NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY END USER, (MARKET SIZE 2023–2030, FORECAST TO 2030 – IN VALUE, USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS, AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
12.2
HOSPITALS & DIAGNOSTIC CENTERS
12.3
ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
12.4
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
12.5
CONTRACT RESEARCH ORGANIZATIONS (CROS)
13
NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2023–2030 (USD MILLION)
ASSESSMENT OF GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY REGIONS AND COUNTRIES
13.2.3
MACROECONOMIC OUTLOOK OF NORTH AMERICA
13.3.7
MACROECONOMIC OUTLOOK OF EUROPE
13.4.6
REST OF ASIA PACIFIC
13.4.7
MACROECONOMIC OUTLOOK OF ASIA PACIFIC
13.5.3
REST OF LATIN AMERICA
13.5.4
MACROECONOMIC OUTLOOK OF LATIN AMERICA
13.6.1.3
REST OF GCC COUNTRIES
13.6.2
REST OF MIDDLE EAST
13.6.3
MACROECONOMIC OUTLOOK OF MIDDLE EAST
13.7.1
MACROECONOMIC OUTLOOK OF AFRICA
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKING INFLUENCING MARKET POTENTIAL
14.2
KEY PLAYERS STRATEGIES/ RIGHT TO WIN
14.3
REVENUE ANALYSIS, 2022–2024
14.4
MARKET SHARE ANALYSIS,
14.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
14.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
14.5.5.1
COMPANY FOOTPRINT
14.5.5.2
REGION FOOTPRINT
14.5.5.4
APPLICATION FOOTPRINT
14.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
14.6.1
PROGRESSIVE COMPANIES
14.6.2
RESPONSIVE COMPANIES
14.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
14.6.5.1
DETAILED LIST OF KEY STARTUPS/ SMES
14.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/ SMES
14.8
VALUATION AND FINANCIAL METRICS
14.9
COMPETITIVE SCENARIO
14.9.3
OTHER DEVELOPMENTS
15.1.1
THERMO FISHER SCIENTIFIC INC.
15.1.4
BIO-RAD LABORATORIES
15.1.5
PROMEGA CORPORATION
15.1.6
AGILENT TECHNOLOGIES
15.1.7
F. HOFFMAN-LA ROCHE LTD.
15.1.8
LGC BIOSEARCH TECHNOLOGIES
16.1.1.1
KEY SOURCES OF SECONDARY DATA
16.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
16.1.2.1
BREAKDOWN OF PRIMARIES
16.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
16.2
MARKET SIZE ESTIMATION
16.2.1
NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET SIZE ESTIMATION
16.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
16.2.1.2
MNM REPOSITORY ANALYSIS
16.2.1.3
SECONDARY ANALYSIS
16.2.1.4
PRIMARY RESEARCH
16.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
16.2.2
SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH)
16.3
MARKET GROWTH RATE PROJECTIONS
16.6
RESEARCH ASSUMPTIONS
16.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3
AVAILABLE CUSTOMIZATIONS
Growth opportunities and latent adjacency in Nucleic Acid Isolation and Purification Kits Market